Interventions Needed To Increase RSV Vaccine Uptake Among Infants, Pregnant Mothers, Study Finds

Infectious Disease Advisor (3/31) reports a study found that “a focused effort to ensure equitable and timely access to respiratory syncytial virus (RSV) vaccines is needed to increase uptake among infants and high-risk pediatric patients in the United States.” Researchers “evaluated RSV immunization coverage among pregnant individuals and infants” and determined the highest maternal RSVpreF vaccine uptake “was observed among patients who identified as non-Hispanic other Asian or Pacific Islander (25.5%), those aged 30 to 44 years (58.8%), and those with private insurance at the time of delivery (21.1%).” In regard to infant immunization coverage, “those born to parents who identified as non-Hispanic American Indian/Alaska Native and those with Medicare or BadgerCare insurance at the time of delivery showed the highest vaccine uptake (20.3% and 19.5%, respectively).” Results from the study were published in Vaccine.